When can we be confident of surgical cure with ctDNA?
Nat Rev Clin Oncol
.
2022 Sep;19(9):571-572.
doi: 10.1038/s41571-022-00664-8.
Authors
Alexander Frankell
1
2
,
Mariam Jamal-Hanjani
3
4
5
Affiliations
1
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. alexander.frankell@crick.ac.uk.
2
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. alexander.frankell@crick.ac.uk.
3
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.
4
Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.
5
Department of Medical Oncology, University College London Hospitals, London, UK. m.jamal-hanjani@ucl.ac.uk.
PMID:
35798966
DOI:
10.1038/s41571-022-00664-8
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Biomarkers, Tumor / genetics
Circulating Tumor DNA* / genetics
Humans
Substances
Biomarkers, Tumor
Circulating Tumor DNA
Grants and funding
17786/CRUK_/Cancer Research UK/United Kingdom
21999/CRUK_/Cancer Research UK/United Kingdom
30025/CRUK_/Cancer Research UK/United Kingdom
DH_/Department of Health/United Kingdom